Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Arlindo R. Ferreira, Antonio Di Meglio, Barbara Pistilli, Arnauld S. Gbenou, Mayssam El-Mouhebb, Sibille Everhard, Charles Coutant, Paul-Henri Cottu, Florence Lerebours, Thierry Petit, Florence Dalenc, Philippe Rouanet, Antoine Arnaud, Anne-Laure Martin, Patricia A. Ganz, Ann H. Partridge, Suzette Delaloge, Stefan Michiels, Fabrice Andre, Ines Maria Vaz Duarte Luis
Institutions: Institut Gustave Roussy, UniCancer Group, Centre Georges François Leclerc, Institut Curie, Université de Strasbourg, Inserm, Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud, Institut Regional du Cancer de Montpellier, University of California, Los Angeles, Dana-Farber Cancer Institute
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947062046